Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vainchenker

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Blood|March 15, 1996
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cellsP Batard, P Sansilvestri, C Scheinecker, et al.
Cell Death and Differentiation|November 13, 2010
Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signalingA-S Gabet, S Coulon, A Fricot, et al.
Oncogene|April 1, 2014
Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulationM Girardot, C Pecquet, I Chachoua, et al.
Cell Death & Disease|July 27, 2012
Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitroH Moniz, M Gastou, T Leblanc, et al.
Blood|November 15, 1995
The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Cell Death & Disease|July 27, 2013
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanismsA Ali, O Bluteau, K Messaoudi, et al.
Cell Death & Disease|October 5, 2012
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse modelY Zhang, S Patel, H Abdelouahab, et al.
Leukemia|October 10, 2008
Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineageB da Costa Reis Monte-Mór, I Plo, A F da Cunha, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Blood|March 15, 1996
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cellsP Batard, P Sansilvestri, C Scheinecker, et al.
Cell Death and Differentiation|November 13, 2010
Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signalingA-S Gabet, S Coulon, A Fricot, et al.
Oncogene|April 1, 2014
Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulationM Girardot, C Pecquet, I Chachoua, et al.
Cell Death & Disease|July 27, 2012
Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitroH Moniz, M Gastou, T Leblanc, et al.
Blood|November 15, 1995
The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Cell Death & Disease|July 27, 2013
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanismsA Ali, O Bluteau, K Messaoudi, et al.
Cell Death & Disease|October 5, 2012
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse modelY Zhang, S Patel, H Abdelouahab, et al.
Leukemia|October 10, 2008
Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineageB da Costa Reis Monte-Mór, I Plo, A F da Cunha, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
Pageof 24